Dynabeads™ Mouse CD4
Dynabeads™ Mouse CD4
Invitrogen™

Dynabeads™ Mouse CD4

Dynabeads™ Mouse CD4 sind magnetische Beads, die ein robustes und vielseitiges Werkzeug zur Isolierung oder zur Depletion von Maus-CD4+-T-Zellen direktWeitere Informationen
Have Questions?
KatalognummerMenge
11445D5 mL
Katalognummer 11445D
Preis (EUR)
1.302,00
Each
Zum Warenkorb hinzufügen
Menge:
5 mL
Preis (EUR)
1.302,00
Each
Zum Warenkorb hinzufügen
Dynabeads™ Mouse CD4 sind magnetische Beads, die ein robustes und vielseitiges Werkzeug zur Isolierung oder zur Depletion von Maus-CD4+-T-Zellen direkt aus jeder Probe bieten, einschließlich Gewebeextrakte wie Milz oder Lymphknoten, Vollblut, Knochenmark und mononukleäre Zellen (MNC).
• Schnelle Isolierung von Maus-CD4+ T-Zellen-Zellen aus jeder Probe – Keine Säulen erforderlich
• Positive Isolierung für molekularnachgelagerte Assays oder effizientes Entfernen von Maus-CD4+ T-Zellen

Ausgezeichnete Ausbeute, Reinheit und Viabilität von regenerierten Zellen
Dynabeads™ Maus CD4 sind einheitliche, superparamagnetische Beads (4,5 µm Durchmesser), die eine einfache Isolierung von Maus-CD4+-Zellen aus Milz- oder Lymphknoten ermöglichen, obwohl jede beliebige Einzelzellsuspension verwendet werden kann. Dynabeads™ Mouse CD4 sind mit einem primären monoklonalen Antikörper beschichtet, der speziell für das CD4-Membranantigen spezifisch ist und hauptsächlich auf Maus-T-Helferzellen exprimiert wird. Dynabeads™ Mouse CD4 binden sich während einer kurzen Inkubationszeit in einem Röhrchen an CD4+-Zellen, danach werden die beadgebundenen Zellen mit einem Magneten von ungebundenen Zellen getrennt. Diese schnelle und schonende Isolierungsmethode erfordert keinen Einsatz von Säulen und trägt dazu bei, hohe Reinheit, Rückgewinnung und Lebensfähigkeit der isolierten CD4+-Zellen zu gewährleisten.

Ideal für die Entfernung und positive Isolierung in nachgelagerten molekularen Assays
Aufgrund der leistungsstarken Magnete für die Trennung kannDynabeads™ Maus-CD4 in viskösen Proben wie Einzelzellsuspensionen aus Gewebe, Vollblut und Knochenmark verwendet werden und ermöglicht die effiziente Entfernung von Maus-CD4+-Zellen in etwa 30 Minuten. Dynabeads™ Mouse CD4 ermöglichen auch eine hervorragende Wiederfindung hochreiner, lebensfähiger Zellen für die Verwendung in nachfolgenden Studien, z. B. wenn Zellen lysiert werden sollen, während sie noch an die Beads gebunden sind, und Nukleinsäuren oder Proteine weiter aufgereinigt werden sollen. Beachten Sie, dass die intakten Zellen von diesen Beads nicht freigesetzt werden. Wenn Sie also Maus-CD4+-Zellen für zellbasierte Anwendungen isolieren möchten oder Ihre Proben mit Durchflusszytometrie überprüfen müssen, sollten Sie DETACHaBEAD™ Maus CD4 in Kombination mit diesen Produkten (für bead- und antikörperfreie Zellen) oder Dynabeads™ FlowComp Maus CD4-Zellen (Komplettkit für beadfreie Zellen) verwenden.

Wählen Sie aus unserem Sortiment an Produkten zur Isolierung von Maus-CD4 aus, was für Sie am besten geeignet ist.

Nur für Forschungszwecke. Nicht für therapeutische oder diagnostische Zwecke bei Menschen oder Tieren vorgesehen.
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
ZelltypT-Zellen (CD4)
IsolierungstechnikNegativisolierung
Anzahl ZellenZur Verarbeitung von insgesamt ∼2 x 10^9 Zellen
Ausgabegrad>95 %
ProduktlinieDYNAL, Dynabeads
Reinheits- oder QualitätsgradForschungsqualität
Menge5 mL
ReaktivitätMaus
ProbentypLymphknoten, Blut, Milz
VersandbedingungRaumtemperatur
Ausgangsmaterial (Zellzahl)1x10^7 Zellen pro Isolierung
ZielspeziesMaus
Durchmesser (metrisch)4,5 μm
ProdukttypAntikörperbeschichteter Bead
Unit SizeEach
Inhalt und Lagerung
Dieses Produkt enthält: 5 ml Dynabeads™ Mouse CD4 (L3T4), mit monoklonalem Anti-L3T4-Antikörper beschichtet.
Das L3T4-Antigen wird auf Maus-Thymozyten und T-Helfer-Subpopulationen reifer
T-Zellen aller gängigen Mausstämme exprimiert.
Bei 2 bis 8 °C lagern.

Häufig gestellte Fragen (FAQ)

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin and MyOne C1 magnetic beads. We recommend our Dynabeads KilobaseBINDER Kit, which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Zitierungen und Referenzen (7)

Zitierungen und Referenzen
Abstract
Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection.
Authors:Verschoor A, Brockman MA, Gadjeva M, Knipe DM, Carroll MC,
Journal:J Immunol
PubMed ID:14607939
'The complement system, in addition to its role in innate immunity, is an important regulator of the B cell response. Complement exists predominantly in the circulation and although the primary source is hepatic, multiple additional cellular sources have been described that can contribute substantially to the complement pool. To date, ... More
Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model.
Authors:Henderson WR, Chi EY, Bollinger JG, Tien YT, Ye X, Castelli L, Rubtsov YP, Singer AG, Chiang GK, Nevalainen T, Rudensky AY, Gelb MH,
Journal:J Exp Med
PubMed ID:17403936
'Arachidonic acid metabolites, the eicosanoids, are key mediators of allergen-induced airway inflammation and remodeling in asthma. The availability of free arachidonate in cells for subsequent eicosanoid biosynthesis is controlled by phospholipase A(2)s (PLA(2)s), most notably cytosolic PLA(2)-alpha. 10 secreted PLA(2)s (sPLA(2)s) have also been identified, but their function in eicosanoid ... More
Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa.
Authors:Roan NR, Starnbach MN,
Journal:J Immunol
PubMed ID:17114470
Following sexual transmission, Chlamydia trachomatis specifically targets genital tract epithelial cells. Because epithelial cells are readily recognized by CD8+ T cells, the response of CD8+ T cells to Chlamydia infection has been explored in a number of studies. It has been shown that CD8+ T cells are present in the ... More
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
Authors:Schillaci R, Salatino M, Cassataro J, Proietti CJ, Giambartolomei GH, Rivas MA, Carnevale RP, Charreau EH, Elizalde PV,
Journal:J Immunol
PubMed ID:16517711
We have demonstrated that in vivo administration of phosphorothioate antisense oligodeoxynucleotides (AS[S]ODNs) to type I insulin-like growth factor receptor (IGF-IR) mRNA resulted in inhibition of C4HD breast cancer growth in BALB/c mice. The present study focused on whether in vivo administration of C4HD tumor cells pretreated with IGF-IR AS[S]ODN and ... More
Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.
Authors:Ali SA, Lynam J, McLean CS, Entwisle C, Loudon P, Rojas JM, McArdle SE, Li G, Mian S, Rees RC,
Journal:J Immunol
PubMed ID:11907113
Direct intratumor injection of a disabled infectious single cycle HSV-2 virus encoding the murine GM-CSF gene (DISC/mGM-CSF) into established murine colon carcinoma CT26 tumors induced a significant delay in tumor growth and complete tumor regression in up to 70% of animals. Pre-existing immunity to HSV did not reduce the therapeutic ... More